“…Initially, it was reported that these motifs could induce in vitro production of interleukin-6 (IL-6) and gamma interferon (IFN-␥) by CD4 ϩ T cells, IL-6 and IL-12 by B cells, and IFN-␥ by NK cells (20). Such properties led to the use of CpG ODNs as adjuvants in several experimental models (11,21,22,23) and, indeed, studies published thus far support the view that Th1-type responses dominate after CpG coadministration with an immunogen. The nature of the immune response developed depends on the age of the animals (2,21), the route of antigen delivery (2), and the nature of the antigen (22); nevertheless, the potential of CpG motifs as adjuvants for delivery via the mucosal surfaces is particularly promising (3,25,26,27).…”